Confirmed Exhibitors

Accord Healthcare is committed to maintaining international standards of quality in the design, manufacture and supply of generic medication, and offers high quality generics in a wide variety of therapeutic areas to the benefit of both private and state healthcare sectors. Our team is deeply invested in contributing to the improvement of medical care for all South Africans.

Merck stands firmly by its motto of Living innovation through its biopharmaceutical division that brings breakthrough solutions to people living with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases. 011 372 5000.

Varian focuses energy on saving lives and is the world’s leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people at sites around the world.

For more information, visit and follow @VarianMedSys on Twitter

Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, hepatitis C and tuberculosis) and cardiovascular and metabolic diseases (e.g. diabetes). Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.

Key Oncologics (Pty) Ltd is a South African pharmaceutical company that primarily focuses on the treatment of cancer and allied diseases.

The company was founded in 1998 representing international companies that do not have an independent presence in South Africa.

Over the years our product profile has grown from a single product to a comprehensive portfolio. We have also diversified into biologics and are in the process of building a generic portfolio. In moving forward Key Oncologics will continue to seek options for patients to live longer and live better.